Pragna Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 17-06-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 35.49 Cr
as on 17-06-2024
- Satisfied Charges ₹ 7.37 Cr
as on 17-06-2024
- Revenue -50.81%
(FY 2023)
- Profit -78.78%
(FY 2023)
- Ebitda -69.34%
(FY 2023)
- Net Worth 7.58%
(FY 2023)
- Total Assets 7.31%
(FY 2023)
About Pragna Life Science
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹35.49 Cr. The company has closed loans amounting to ₹7.37 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jigneshkumar Patel, Chiragkumar Patel, and Dipakkumar Patel serve as directors at the Company.
- CIN/LLPIN
U24239GJ2012PTC070925
- Company No.
070925
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ankleshwar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pragna Life Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jigneshkumar Patel  | Director | 26-Jun-2012 | Current |
| Chiragkumar Patel | Director | 20-Aug-2020 | Current |
| Dipakkumar Patel | Director | 04-Feb-2014 | Current |
Financial Performance of Pragna Life Science.
Pragna Life Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 50.81% decrease. The company also saw a substantial fall in profitability, with a 78.78% decrease in profit. The company's net worth moved up by a moderate rise of 7.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pragna Life Science?
In 2023, Pragna Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pragna Speciality Private LimitedActive 3 years 9 monthsJigneshkumar Patel and Dipakkumar Patel are mutual person
Pragna Pharma Private LimitedActive 12 years 11 monthsJigneshkumar Patel and Dipakkumar Patel are mutual person
Bhavik Chem Private LimitedActive 12 years 11 monthsJigneshkumar Patel and Dipakkumar Patel are mutual person
- Pragna Fine Chem Private LimitedActive 4 years 6 months
Jigneshkumar Patel and Dipakkumar Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Aug 2022 | ₹4.00 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Jan 2021 | ₹31.49 Cr | Open |
Hdfc Bank Limited Creation Date: 14 Feb 2018 | ₹2.47 Cr | Satisfied |
How Many Employees Work at Pragna Life Science?
Pragna Life Science has a workforce of 43 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pragna Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pragna Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
